News Articles for Arovella Therapeutics

Our board moves wrap includes Tom Duthy, Graeme McCracken, Ben Secrett, Sophie Raven, Christine He, Julian Hoskin, JunChao Liu, Kevin Dundo, Andrea Sutton, and Tommy Logtenberg.

Arovella Therapeutics' announcement to close its local R&D facility is unfortunate timing given major conference AusBiotech opens in Perth today.

Our board moves wrap includes Gary Phillips, Lisa Wynne, Sarah Sutcliffe, Adrian Gurgone, Brian Miller, Tara French, Bob Osmetti, Mark Calderwood, Nicholas Katris, Jessamyn Lyons, John Madden, and Tom Eadie.

Our board moves wrap includes Andrew Tunks, Paul Hopper, Elizabeth Stoner, Darren Cooke, William Nguyen, Sandra Bates, Michael Kitney, Andrew Bald, and David McArthur.

If billionaire “prospector” Mark Creasy has the Midas touch when it comes to divining lucrative mineral deposits, Paul Hopper just might be the man who wields the mythical rod of Asclepius - the Greek God of medicine - when it comes to the equally lucrative ASX-listed biotechnology space. By any measure Hopper has experienced success listing and developing biotech companies on the ASX – and the last year was a good one.

Cancer fighting biotech, Radiopharm Theranostics has gained access to a rare medical isotope from a Bill Gates start-up to accelerate the development of its pipeline of cancer treatment therapies. The company says “actinium-225” is a radioactive isotype that can be attached to a targeting antibody that will then selectively target and destroy cancerous tissue.

Our board moves wrap includes David Phillips, Michael Baker, Elizabeth Stoner, Simon Lawson, and Jens Balkau.

Our board moves wrap includes Nick de Blocq and Debora Barton.

Our weekly appointments wrap includes Janelle Marr, Barry Sargeant, Chris Melsom, Libby Lyons, Damon Sugden, Kate O'Hara, Anjie Brook, Joe Scurria, Michelle Keegan, Michael Morgan, Melissa Roberts and Sandhya Buchanan.

Our board moves wrap includes Vincent Ledoux-Pedailles, David McArthur, Gregory Channon, Chris Hodge, Joseph Ohayon, and Phillip Hains.

Our board moves wrap includes Warren Harding, Craig Masarei, Sean Maher, Michael Pixley, Shannon Coates, Matthew Foy, Andy Goodwin, Paul Ladislaus, Ashok Parekh, Peter Bilbe, Bernie Ridgeway, Paul House, Dean Hildebrand, Geoff Brayshaw, Karl Paganin, William Kuan, Sally Langer, Maree Arnason, Robert Scott, Phillip Hains, Alfred Gillman, Christopher Knee, Keong Kok Chan, Peter Williams, Graeme Smith, and Bret Silvey.

Scott Criddle will be stepping down as executive director of Decmil Group at the end of July. His resignation is the first part of a planned renewal of the company's board.

Dan Smetana will be retiring as non-executive director of Korab Resources at the start of next year. Mr Smetana has been with the company since 2013.

Neil Whitaker, current chief executive of Nusantara Resources, has been appointed to the board as a director.

Our weekly appointments wrap includes David Gainer, Andrew Hammond, Len Kosova, Phil Thick, Derek Hays, Warren Hallam, Dan Foo, Thomas Currin, Tim Roach, Richard Frankli

Zenith Energy has closed its share purchase plan with applications totalling $220,000 of the total $5 million that was offered.

Our daily board moves wrap includes Todd Richardson, Rod Evans, Paul Hopper, Stephen Carter, HongBing Zhang, RuoYun Zhang, Tun Yiu Kei, Tommy Cheng, and Edward Siew.

Great Southern Mining has received commitments from sophisticated investors for the placement of 34 million shares at an issue price of $0.0375 a share to raise approximately $1.275 million.

Brett Fraser has been appointed non-executive director of Sundance Resources.

S2 Resources advises that completion has occurred under the Heads of Agreement that was announced on 14th February 2018.

Perth-based drug company Suda has raised $5.6 million to be used for its ArTiMist malaria treatment and other development products.

Suda's fully-owned subsidiary Westcoast Surgical and Medical Supplies has reported its strongest quarter to date.

Perth-based Eastland Medical plans to offload more subsidiaries after it today accepted a $1.8 million offer to sell subsidiary Medical Industries Australia.

Eastland Medical Systems plans to raise more than $2 million, partly underwritten by Patersons Securities, to fund the final step of its anti-malaria treatment project.

A subsidiary of Perth-based Eastland Medical Systems Ltd has moved to secure a €42 million ($A70 million) to complete the manufacturing plant for its anti malaria treatment in Germany.

Perth-based Eastland Medical Systems Ltd says it is on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi-dose Phase 1 clinical trial in February, after its pharmaceutical division received regulatory approvals i

Perth-based Eastland Medical Systems Ltd has acquired New South Wales-based Phoenix Medical Equipment Services Pty Ltd in a cash andscrip deal valued at $90,000, the company has announced.

Perth-based Eastland Medical Systems Ltd will take a controlling stake in African drug developer Star Medical (Botswana) Ltd after acquiring a further 25 per cent of the company through a scrip issue worth $1 million, the company has announced.

West Perth-based Eastland Medical Systems Ltd has secured approval to commence the final stage of the single dose Phase 1 clinical testing of its new anti-malaria treatment in Malaysia.

West Perth-based Eastland Medical Systems Ltd has acquired the distribution rights for a nicotine replacement therapy as part of a deal signed with German pharmaceutical company hc Berlin Pharma AG.

West Perth-based medical company Eastland Medical Systems Ltd has acquired a 30 per cent stake of African drug developer Star Medical (Botswana) Ltd for $900,000, the company announced today.

WEST Perth-based medical device manufacturer, Eastland Medical Systems, has secured a contract, through its South African subsidiary, to produce anti-malaria medication for the African continent.

West Perth-based Eastland Medical Systems Ltd's South African subsidiary Eastland Medical Systems South Africa Ltd will produce anti-malaria medication for the entire continent under a new agreement with Star Medical (Botswana) Ltd.

West Perth-based Eastland Medical Systems Ltd has concluded the sale of its shareholding in the UK AIM listed company International Medical Devices PLC for a consideration of $2.5million.

West Perth-based medical company Eastland Medical Systems Ltd has won exclusive distribution rights for a children's anti-malaria treatment in Sub-Saharan Africa, the company announced today.

West Perth company Eastland Medical Systems Ltd announced that UK based Response Medical Equipment Ltd has obtained European regulatory approval for its ClipOn hypodermic needle, clearing the way for commercial sales in European markets.

West Perth-based Eastland Medical Systems Ltd will raise $2 million through a placement to ACON Actinebank, for purposes of strategic growth and attracting foreign investment.

One day after the announcement of his resignation as chief executive of embattled Welshpool water and power company Solco Ltd, Dermot Patterson has been appointed chief executive of West Perth's Eastland Medical Systems Ltd.

West Perth-based medical company Eastland Medical Systems Ltd has announced its second acquisiton this week, with the purchase of healthcare products provider EMS Medical Ltd UK.

West Perth-based company Eastland Medical Systems Ltd has acquired 50 per cent of Erskine-based sterile barrier and packaging products manufacturer Ampack Medical Pty Ltd.